William Garrett Gray
2018
In 2018, William Garrett Gray earned a total compensation of $435.8K as Vice President, Finance and Accounting at Checkpoint Therapeutics, a 110% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $57,375 |
|---|---|
| Salary | $170,000 |
| Stock Awards | $200,000 |
| Other | $8,437 |
| Total | $435,812 |
Gray received $200K in stock awards, accounting for 46% of the total pay in 2018.
Gray also received $57.4K in non-equity incentive plan, $170K in salary and $8.4K in other compensation.
Rankings
In 2018, William Garrett Gray's compensation ranked 12,306th out of 14,244 executives tracked by ExecPay. In other words, Gray earned more than 13.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,306 out of 14,244 | 14th |
Division Manufacturing | 4,977 out of 5,765 | 14th |
Major group Chemicals And Allied Products | 1,879 out of 2,128 | 12th |
Industry group Drugs | 1,607 out of 1,817 | 12th |
Industry Pharmaceutical Preparations | 1,232 out of 1,391 | 11th |
Source: SEC filing on April 30, 2019.
Gray's colleagues
We found one more compensation record of an executive who worked with William Garrett Gray at Checkpoint Therapeutics in 2018.
2018
James Oliviero
Checkpoint Therapeutics
Chief Executive Officer
News
Checkpoint Therapeutics CEO James Oliviero's 2021 pay stays at $2.3M
April 29, 2022
Checkpoint Therapeutics CEO James Oliviero's 2020 pay slips 1% to $2.3M
April 30, 2021
Checkpoint Therapeutics CEO James Oliviero's 2019 pay rises 8% to $2.3M
April 24, 2020
Checkpoint Therapeutics CEO James Oliviero's 2018 pay jumps 230% to $2.1M
April 30, 2019